Effectiveness of a Guided Mobile App Intervention for Depression and Anxiety in University Students (PROMES-U Study)
NCT ID: NCT06078007
Last Updated: 2024-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
600 participants
INTERVENTIONAL
2024-10-25
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: two-arm multicenter randomized controlled trial (RCT), addressed to undergraduate students from 6 public universities with symptoms of depression and/or anxiety. Students will be evaluated through an online survey assessing mental health problems, use of mental health services, sociodemographic variables, self-perceived health, childhood and adolescent adversities, recent stressful events, social networks, personality and university experiences. A total of 600 students will be randomly assigned to: intervention group (guided E-health prevention intervention) or control group (treatment as usual with self-monitoring). The intervention, in app format, is based on principles of cognitive behavioral therapy, includes weekly feedback based on content and participation from a psychologist and self-monitoring. Assessments will take place post-intervention (up to 6 weeks), at 6 months and 12 months after randomization. The primary outcome will be the reduction of depressive or anxiety symptoms post-intervention, assessed with the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder-7 (GAD-7) and the Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS). Secondary outcomes of the RCT will be mental wellbeing, academic stress, comorbid symptoms, and adherence. Analyses will be conducted on an intention-to-treat and per protocol basis.
Discussion: The results of the PROMES-U RCT will provide valuable information on a guided preventive online intervention that could be delivered in the campus context. In addition, results will provide information on the positive impact of the intervention on other relevant factors involved in mental health among university students.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Indicated Prevention Transdiagnostic Intervention for Adolescents At High Risk of Emotional Problems
NCT05252026
Efficacy of a Mobile Phone App for Depression and Anxiety in College Students
NCT06628830
Development of a Multiplatform Mental Health Mobile Tool
NCT05997849
Selective Prevention Transdiagnostic Intervention for At-risk Adolescents
NCT04851366
The Unified Protocol for the Treatment of Emotional Disorders in Spanish Public Mental Health System
NCT03064477
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MyMoodCoach Intervention
MyMoodCoach
The MyMoodCoach prevention intervention is an evidence-based online intervention based on cognitive-behavioral therapy principles such as behavioral activation, problem solving and challenging negative thoughts.
Treatment-as-usual monitoring control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MyMoodCoach
The MyMoodCoach prevention intervention is an evidence-based online intervention based on cognitive-behavioral therapy principles such as behavioral activation, problem solving and challenging negative thoughts.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having 18 years of age or more
* Having literacy in Spanish
* Having access to a smartphone (Android or Apple)
* With mild or moderate depression and/or anxiety symptoms screened (i.e., depression (5≤ (PHQ-9) ≤14); and/or anxiety (5≤ GAD-7 ≤14).
Exclusion Criteria
* High suicide risk
* A history of severe psychiatric disorder (e.g., bipolar, psychosis)
* Being on mental health treatment (i.e., medication, psychotherapy or other intervention)
Students with high suicide risk will receive a clinical alert recommending them to visit a specialist and a list of available mental health resources.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital del Mar Research Institute (IMIM)
OTHER
Universitat Jaume I
OTHER
Universidad Miguel Hernandez de Elche
OTHER
Universitat Pompeu Fabra
OTHER
Universidad de Zaragoza
OTHER
University of Malaga
OTHER
Instituto de Salud Carlos III
OTHER_GOV
University of the Balearic Islands
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jordi Alonso
Role: PRINCIPAL_INVESTIGATOR
Hospital de Mar Medical Research Institute (IMIM)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Miquel Roca
Palma de Mallorca, Balearic Islands, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020/9198/I
Identifier Type: OTHER
Identifier Source: secondary_id
PI20/00006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.